Author:
Brown Kate G.,Chen Carina Y.,Dong Deanna,Lake Kimberly J.,Butelman Eduardo R.
Abstract
Abstract
Background
Nursing professionals are vitally involved in the cascade of care for opioid use disorders (OUDs). The global spread of COVID-19 has had complex effects on public health aspects of major diseases, including OUDs. There are limited data on the major ways in which the COVID-19 pandemic has affected the functions of nursing professionals in the care of OUDs.
Method
This systematic review followed Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines and examined published data for trends in OUD care during the first 2 years of the COVID-19 pandemic, focusing on nursing functions. The National Library of Medicine PubMed database and the EMBASE database were examined for peer-reviewed studies with primary data published between January 1, 2020, and December 31, 2021.
Review Findings and Conclusions
Rapid changes were observed in numerous aspects of OUDs during the early pandemic stage, as well as its care by nursing and other health professionals. These changes include increased overdoses (primarily from synthetic opioids such as fentanyl) and emergency department visits. These trends varied considerably across U.S. jurisdictions, underscoring the importance of region-specific examinations for public health policy and intervention. Out of necessity, healthcare systems and nursing professionals adapted to the challenges of OUD care in the pandemic. These adaptations included increases in telehealth services, increases in take-home doses of methadone or buprenorphine/naloxone, and expansion of layperson training in the use of naloxone for overdose reversal. It is likely that some of these adaptations will result in long-term changes in standards of care practices for OUDs by nursing professionals.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference45 articles.
1. Telehealth for opioid use disorder treatment in low-barrier clinic settings: An exploration of clinician and staff perspectives;Harm Reduction Journal,2021
2. Computing the effects of SARS-CoV-2 on respiration regulatory mechanisms in COVID-19;ACS Chemical Neuroscience,2020
3. U-47700 and its analogs: Non-fentanyl synthetic opioids impacting the recreational drug market;Brain Sciences,2020
4. The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months;The International Journal on Drug Policy,2021
5. Well-being of health care professionals treating opioid use disorder during the COVID-19 pandemic: Results from a National Survey;Psychiatric Services,2021